March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bio's lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The company's pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.

March Biosciences

March Biosciences' headquarters in Houston, TX, United States

Sarah Hein

Description

People (5)

Sarah Hein

Max Mamonkin

Federica Giordano

Eric Smith

Olga Meystelman

Jobs